Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases

Thursday, May 12, 2022

Nuvig Therapeutics Inc announced today the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function To support this mission the company...

Neuvivo Begins Manufacturing of NP001 for Treatment of ALS

Thursday, May 12, 2022

Neuvivo a biopharmaceutical company dedicated to delivering an effective safe ALS treatment to patients today announced that it has initiated cGMP manufacturing of NP for the treatment of ALS Lou Gehrigs Disease The company expects to have product a...

Pfizer to Acquire Biohaven Pharmaceuticals

Wednesday, May 11, 2022

Pfizer Inc and Biohaven Pharmaceutical Holding Company Ltd announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven the maker of NURTEC ODT an innovative dualacting migraine therapy approved for b...

Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance

Wednesday, May 11, 2022

Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics The QualTrak comprehensive suite of qPCR tools is comprised of a premium selection o...

OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases

Tuesday, May 10, 2022

OPKO Health Inc a multinational biopharmaceutical and diagnostics company today announced the acquisition of ModeX Therapeutics Inc a privately held biotechnology company focused on developing innovative multispecific immune therapies for cancer and...

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine

Tuesday, May 10, 2022

Hitachi HighTech Corporation has entered into a strategic partnership the Partnership with Invivoscribe Inc a global provider of blood cancer testing kits and services by undertaking a minority investmentbased thirdparty allotment of shares The Partn...

Citius Pharmaceuticals to Accelerate Phase 3 Mino-Lok Trial by Expanding Trial Sites Internationally

Monday, May 09, 2022

Citius Pharmaceuticals Inc a latestage biopharmaceutical company developing and commercializing firstinclass critical care products today announced that it has selected Biorasi LLC Biorasi a global clinical research organization CRO to help expand th...

AbbVie Chooses Cerebras Systems to Accelerate AI Biopharmaceutical Research

Friday, May 06, 2022

Cerebras Systems the pioneer in high performance artificial intelligence AI computing and AbbVie a global biopharmaceutical company today announced a landmark achievement in AbbVies AI work Using a Cerebras CS on biomedical natural language processin...

Algernon Pharmaceuticals Announces Last Patient Treated in Phase 2 Study of IPF and Chronic Cough

Friday, May 06, 2022

Algernon Pharmaceuticals Inc a clinical stage pharmaceutical development company is pleased to announce that the last patient has completed the treatment period in its Phase proof of concept study of NP Ifenprodil for idiopathic pulmonary fibrosis I...

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

Thursday, May 05, 2022

Brickell Biotech Inc a clinicalstage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune inflammatory and other debilitating diseases announc...